Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Cancer Metastatic × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Head and Neck Neoplasms 1867 Squamous Cell Carcinoma of Head and Neck 1448 Nasopharyngeal Carcinoma 463 Thyroid Neoplasms 421 Carcinoma, Non-Small-Cell Lung 382 Breast Neoplasms 283 Mouth Neoplasms 282 Neoplasms 273 Melanoma 259 Oropharyngeal Neoplasms 254 Colorectal Neoplasms 243 Lung Neoplasms 212 Carcinoma, Squamous Cell 211 Ovarian Neoplasms 197 Neoplasm Metastasis 197 Salivary Gland Neoplasms 176 Stomach Neoplasms 175 Uterine Cervical Neoplasms 170 Laryngeal Neoplasms 169 Nasopharyngeal Neoplasms 163 Pancreatic Neoplasms 157 Esophageal Neoplasms 157 Carcinoma, Renal Cell 154 Prostatic Neoplasms 141 Sarcoma 123 Urinary Bladder Neoplasms 119 Triple Negative Breast Neoplasms 118 Recurrence 111 Endometrial Neoplasms 111 Hypopharyngeal Neoplasms 103

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡